- Home
- USNA
as 04-18-2025 1:44pm EST
Usana Health Sciences Inc is a direct selling and direct-to-consumer nutrition, personal health and wellness company. It developed and manufactured science-based nutritional, personal care and skincare products with a focus on promoting long-term health and wellness. The company has two reportable segments: direct selling and Hiya direct-to-consumer. The direct selling segment develops and manufactures high quality, science-based nutritional, personal care and skincare products with a focus on promoting long-term health and wellness in various geographic markets that are distributed through the direct selling channel. The Hiya direct-to-consumer segment is a provider of children's health and wellness products in the U.S. Key revenue is generated from Direct selling segment.
Upcoming Earnings Alert:
Get ready for potential market movements as USANA Health Sciences Inc. USNA prepares to release earnings report on 22 Apr 2025.
| Founded: | 1992 | Country: | United States |
| Employees: | 1700 | City: | SALT LAKE CITY |
| Market Cap: | 461.9M | IPO Year: | 1996 |
| Target Price: | $36.00 | AVG Volume (30 days): | 230.6K |
| Analyst Decision: | Hold | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 2.19 | EPS Growth: | -33.64 |
| 52 Week Low/High: | $23.26 - $49.78 | Next Earning Date: | 04-22-2025 |
| Revenue: | $854,503,000 | Revenue Growth: | -7.22% |
| Revenue Growth (this year): | 14.62% | Revenue Growth (next year): | 6.90% |
Stock Insider Trading Activity of USANA Health Sciences Inc. (USNA)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Neidig Brent | USNA | CHIEF COMMERCIAL OFFICER | Mar 12 '25 | Sell | $32.34 | 4,743 | $153,387.20 | 0 | |
| Foukas Joshua | USNA | CHIEF LEGAL OFFICER | Mar 12 '25 | Sell | $32.54 | 5,732 | $186,513.55 | 0 | |
| Fleming John Turman | USNA | Director | Mar 11 '25 | Sell | $33.30 | 500 | $16,647.70 | 4,026 | |
| Mulham David Mulham | USNA | CHIEF SALES OFFICER | Mar 10 '25 | Sell | $32.98 | 3,234 | $106,669.93 | 12,775 | |
| FULLER GILBERT A | USNA | Director | Mar 6 '25 | Sell | $31.44 | 674 | $21,190.43 | 0 | |
| Brown Jim | USNA | CEO & PRESIDENT | Mar 3 '25 | Sell | $29.47 | 5,000 | $147,350.00 | 15,716 | |
| Pelosi Peggie | USNA | Director | Feb 27 '25 | Sell | $28.10 | 780 | $21,918.00 | 3,395 |
Latest USANA Health Sciences Inc. News
USNA Breaking Stock News: Dive into USNA Ticker-Specific Updates for Smart Investing
Argus Research
5 days ago
USNA: What does Argus have to say about USNA?
MT Newswires
6 days ago
USANA Health Sciences Says Skin Treatment Study Shows Significant Improvements in Appearance
PR Newswire
6 days ago
Clinical Study Shows USANA Celavive's Resurfacing Serum to Improve Appearance of Skin in Just Two Weeks
Simply Wall St.
7 days ago
Capital Allocation Trends At USANA Health Sciences (NYSE:USNA) Aren't Ideal
Zacks
10 days ago
Ionis Pharmaceuticals (IONS) Surges 8.9%: Is This an Indication of Further Gains?
Argus Research
12 days ago
USNA: Lowering target price to $25.00
Business Wire
12 days ago
USANA Schedules First Quarter 2025 Earnings Release and Conference Call
Argus Research
19 days ago
USNA: Raising target price to $29.00
Compare USNA vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "USNA USANA Health Sciences Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.